hme

Relapsed/refractory multiple myeloma updates at ASH 2020: How can we integrate the latest data into patient management?

Agenda

Learning objective:

After participating in this broadcast you should be able to:

  • Discuss the potential impact of data presented at the American Society of Hematology (ASH) 2020 congress on the management of patients with relapsed/refractory multiple myeloma

 

Moderator:

  • Mohamad Mohty (France)

 

Faculty:

  • Meletios Dimopoulos (Greece)
  • Michel Delforge (Belgium)

More Info
62 Minutes
EM-43700 - Date of preparation: October 2020